drugset / Trial / NCT00170859

Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients

NCT00170859 ↗

Phase 4 Completed Novartis Pharmaceuticals
RandomizedParallel-groupOpen-labelPrevention

Summary

In this study two immunosuppressive regimens (everolimus in combination with cyclosporine microemulsion and mycophenolate mofetil with cyclosporine microemulsion) with reduced dose cyclosporine microemulsion are compared in maintenance heart transplant recipients with impaired renal function.

Timeline

Start
2004-08
Primary completion
2006-11
Completion
2006-12

Outcome

Missed primary endpoint

paper Noninferiority of the everolimus regimen could not be shown: PMID 23953553 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule — —

Indications

No indication recorded.